About us

We are shaping the future of oncology

Our exceptional team of experts brings together profound knowledge in genomics, machine learning, and oncology, propelling us to the forefront of research and innovation in cancer treatment.

Leadership

Founded to change the world

Gordion Bioscience was founded by field-leading academics, aiming to merge insights on Synthetic Lethality with cutting-edge genomic data exploration and Machine Learning.

Pawel Zawadzki
CEO
Kasia Zawadzka
COO
Pawel Sztromwasser
CTO

Scientific Advisory Board

Knowledge is the key

Mark Swindells
previously
prof. David Sherratt
prof. Marcin Nowotny
Peter Takacs,
PhD
Alex Koenig,
PhD
Jurgen Moll,
PhD

Partners and investors